3 Russell 2000 Stocks with Open Questions

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CENT Cover Image

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Picking the right small caps isn’t easy, and that’s exactly why StockStory exists - to help you focus on the best opportunities. Keeping that in mind, here are three Russell 2000 stocks to steer clear of and some alternatives to watch instead.

Central Garden & Pet (CENT)

Market Cap: $2.14 billion

Enhancing the lives of both pets and homeowners, Central Garden & Pet (NASDAQ:CENT) is a leading producer and distributor of essential products for pet care, lawn and garden maintenance, and pest control.

Why Does CENT Fall Short?

  1. Annual sales declines of 1% for the past three years show its products struggled to connect with the market
  2. Sales are expected to decline once again over the next 12 months as it continues working through a challenging demand environment
  3. Below-average returns on capital indicate management struggled to find compelling investment opportunities

Central Garden & Pet’s stock price of $37.76 implies a valuation ratio of 12.8x forward P/E. Check out our free in-depth research report to learn more about why CENT doesn’t pass our bar.

Privia Health (PRVA)

Market Cap: $2.60 billion

Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ:PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models.

Why Is PRVA Not Exciting?

  1. Revenue base of $2.25 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
  2. Poor free cash flow margin of 5% for the last five years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
  3. ROIC of -0.6% reflects management’s challenges in identifying attractive investment opportunities

Privia Health is trading at $20.66 per share, or 19.8x forward P/E. Read our free research report to see why you should think twice about including PRVA in your portfolio.

Stewart Information Services (STC)

Market Cap: $1.91 billion

Founded in 1893 during America's westward expansion when property records were often disputed, Stewart Information Services (NYSE:STC) provides title insurance and real estate services, helping homebuyers, sellers, and lenders verify property ownership and protect against title defects.

Why Do We Think Twice About STC?

  1. Growth in insurance policies was lackluster over the last five years as its 1.2% annual growth underperformed the typical financial institution
  2. Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 6.5% annually
  3. Muted 4.6% annual book value per share growth over the last two years shows its capital generation lagged behind its insurance peers

At $62.57 per share, Stewart Information Services trades at 1.1x forward P/B. If you’re considering STC for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article